Anzeige
Mehr »
Mittwoch, 16.07.2025 - Börsentäglich über 12.000 News
Klinisch validiert. Vertriebsbereit. Und kurz vor der FDA-Zulassung.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 932242 | ISIN: IE0005711209 | Ticker-Symbol: IJF
Tradegate
16.07.25 | 09:31
125,05 Euro
-0,40 % -0,50
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ICON PLC Chart 1 Jahr
5-Tage-Chart
ICON PLC 5-Tage-Chart
RealtimeGeldBriefZeit
125,05126,1513:20
125,05126,1513:14

Aktuelle News zur ICON Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
Leser Medien
13:18ICON plc: ICON's Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report6ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research organisations (CRO) for phase 1...
► Artikel lesen
DiDo You Believe in the Upside Potential of ICON PLC (ICLR)?1
ICON Aktie jetzt für 0€ handeln
09.07.ICON plc stock price target lowered to $187 at Truist Securities5
07.07.ICON plc: ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability244ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2025 with a number of business awards, recognising the...
► Artikel lesen
26.06.Should You Hold ICON PLC (ICLR)?15
23.06.ICON plc Schedules Second Quarter 2025 Earnings Conference Call228ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that it will release its financial results for the second quarter 2025...
► Artikel lesen
18.06.ICON PLC - 6-K, Report of foreign issuer1
11.06.ICON PLC - 6-K, Report of foreign issuer2
02.06.Here's Why You Should Retain ICLR Stock in Your Portfolio Now14
27.05.ICON plc wird auf der jährlichen Growth Stock Konferenz präsentieren8
27.05.ICON plc to Present at the William Blair 45th Annual Growth Stock Conference283ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the William Blair...
► Artikel lesen
27.05.ICON PLC - 6-K, Report of foreign issuer4
19.05.ICON PLC - 6-K, Report of foreign issuer1
19.05.ICON plc: ICON releases its ICON Cares 2024 Report409ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today releases its ICON Cares 2024 Report. The report outlines how the company is delivering...
► Artikel lesen
07.05.ICON plc: Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies275ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a survey of 155 biotech and pharma professionals from across...
► Artikel lesen
30.04.ICON plc: ICON Reports First Quarter 2025 Results590Highlights Net business wins in the quarter of $2,022 million; a net book to bill in the quarter of 1.01. Closing backlog of $24.7 billion, an increase of 0.3% on quarter four 2024 and...
► Artikel lesen
30.04.ICON PLC - 6-K, Report of foreign issuer2
27.04.ICON Public Limited Company (ICLR): Among the Oversold Growth Stocks to Buy Now15
10.04.What Makes Icon PLC (ICLR) an Investment Bet?22
03.04.LVS Advisory Sold Icon Plc (ICLR) After Identifying Flaws in its Investment Thesis12
Weiter >>
55 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1